Biogen Inc. (BIIB) Profit Margins
Over the twelve months to 2026-06-30, Biogen Inc. (BIIB) had gross margin 74.0%, net margin 8.3%, free cash flow margin 26.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BIIBBiogen Inc.Follow BIIB — free
—
Price chart with a free account
- Market cap
- 37.0B
- P/E TTM
- 44.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 91.3% | 91.5% | 90.8% | 90.1% | 87.6% | 87.9% | 88.5% | 87.1% | 86.7% | 86.5% | 86.4% | 86.6% | 80.8% | 77.6% | 74.2% | 76.1% | 75.7% | 74.0% | |
| Operating margin | 29.6% | 26.5% | 34.2% | 33.6% | 36.3% | 40.9% | 45.4% | 45.0% | 43.6% | 43.8% | 49.0% | 33.8% | 25.9% | — | — | — | — | — | |
| Net margin | 22.2% | 21.3% | 24.5% | 25.0% | 26.9% | 30.2% | 33.0% | 32.3% | 20.7% | 32.9% | 41.0% | 29.8% | 14.2% | 29.9% | 11.8% | 16.9% | 13.1% | 8.3% | |
| FCF margin | 20.8% | 30.8% | 30.1% | 29.5% | 30.3% | 27.4% | 30.4% | 34.7% | 30.0% | 40.3% | 45.7% | 28.3% | 30.8% | 11.2% | 12.9% | 28.1% | 20.7% | 26.9% |
USD billions · SEC XBRL
Biogen Inc. — questions
- What is Biogen Inc.'s gross margin?
- 74.0% over the twelve months to 2026-06-30.
- What is Biogen Inc.'s net profit margin?
- 8.3% over the twelve months to 2026-06-30.
Every figure on this page comes from Biogen Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.